Saturday 17 October 2026 Export ALKS’s income statement to Excel — free account

Alkermes plc

ALKS Healthcare Drug Manufacturers Specialty & Generic

Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024. In the quarter to June 2026, revenue grew 27.0%, EPS fell 99.4% and free cash flow grew 1.13%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

41.22 1.12 +2.79%

Follow ALKS

Alert me

Market cap: $6.7B
P/E: 102×
Fwd P/E: −108×
Dividend yield: —
F-score: 7/9
Altman Z: 5.33
Beneish M: −3.29
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	14.49	19.03	38.02	130.02
P/S ratio Full definition →		3.26	3.12	3.76	5.25
P/FCF ratio Full definition →		10.09	9.57	26.57	39.30
P/Operating CF Full definition →		48.71	27.10	(35.46)	60.28
P/B ratio Full definition →		2.86	2.53	3.36	4.84
Price to Tangible BV Full definition →		3.00	2.66	0.00	0.00
EV/Sales Full definition →		2.71	2.42	4.40	5.76
EV/EBITDA Full definition →		10.63	12.73	28.20	43.12
EV/Operating CF Full definition →		7.63	6.87	26.84	38.21
EV/FCF Full definition →		8.41	7.43	31.08	43.10
Quick Ratio Full definition →		3.09	3.04	1.53	1.68
Current Ratio Full definition →		3.67	3.55	2.27	2.30
Net Debt/EBITDA Full definition →		(11.44)	(21.30)	(61.92)	10.63
Debt/Assets Full definition →		0.00%	0.00%	35.47%	34.22%
Debt/Equity Full definition →		0.00	0.00	0.86	0.83
Asset Turnover Full definition →		0.68	0.65	0.49	0.50
Operating CF/Net income Full definition →		1.23	3.45	2.49	289.79
Capex/Depreciation Full definition →		(2.14)	0.28	(0.13)	(0.13)
Interest Coverage Full definition →		—	—	(2.31)	0.71
Research and Development Expense of Revenue Full definition →		20.74%	24.19%	26.30%	22.77%
Selling, General and Administrative Expense of Revenue Full definition →		43.58%	48.68%	67.34%	43.88%
Intangible Assets out of Total Assets Full definition →		0.04	0.03	0.56	0.54
Share Based Compensation of Revenue Full definition →		6.26%	6.83%	9.25%	6.28%
Graham Net Nets Full definition →		0.23	0.27	(0.20)	(0.12)
Graham Number Full definition →		22.11	19.11	14.85	9.91
Earnings Yield Full definition →		6.90%	5.25%	2.63%	0.77%
Free Cash Flow Yield Full definition →		9.91%	10.45%	3.76%	2.54%
Revenue per Share Full definition →		2.39	2.33	2.36	2.97
Operating CF per Share Full definition →		0.62	1.03	(1.00)	0.87
Capex per Share Full definition →		(0.10)	0.01	(0.02)	(0.05)
Free Cash Flow per Share Full definition →		0.51	1.04	(1.02)	0.82
Cash per Share Full definition →		6.73	8.01	3.08	3.93
Shareholders Equity per Share Full definition →		10.50	11.05	10.54	10.83
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		10.50	11.05	10.54	10.83
Free Cash Flow Full definition →		84.36	171.14	(169.82)	137.04
Working Capital Full definition →		1,267.30	1,385.72	759.15	860.82
Capital Expenditures Full definition →		(17.31)	1.07	(4.08)	(8.15)
Net Current Asset Value Full definition →		1,145.58	1,261.46	(1,147.90)	(1,061.67)
EV/EBIT Full definition →		11.52	14.09	35.83	81.86
Capex to Sales Full definition →		0.04	0.00	0.01	0.02
Price to Operating Income Full definition →		13.81	18.15	30.63	74.64
Other line items
Average Receivables Full definition →		360.80	359.28	363.17	405.69
Average Payables Full definition →		187.59	237.45	239.31	289.11
Average Inventory Full definition →		191.04	189.76	260.07	245.44
Average Assets Full definition →		2,242.40	2,271.28	3,170.03	3,322.97
Average Common Equity Full definition →		1,512.77	1,642.14	1,631.56	1,716.57

Fold the line items

Columns are period end dates

Stockrow Weekly